ACM
Aquilo Capital Management Portfolio holdings
AUM
$37.1M
This Quarter Return
+3.38%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
–
AUM
$385M
AUM Growth
+$385M
(+5%)
Cap. Flow
+$27.1M
Cap. Flow
% of AUM
7.03%
Top 10 Holdings %
Top 10 Hldgs %
88.77%
Holding
17
New
–
Increased
10
Reduced
2
Closed
–
Top Buys
| 1 |
4D Molecular Therapeutics
FDMT
|
$15.5M |
| 2 |
uniQure
QURE
|
$6.22M |
| 3 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$4.12M |
| 4 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$4.03M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$2.24M |
Top Sells
| 1 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
$11.7M |
| 2 |
PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
|
$1.83M |
Sector Composition
| 1 | Healthcare | 82.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $67.7M | 17.58% |
1,813,392
+108,000
| +6% | +$4.03M |
|
2
Spero Therapeutics
SPRO
$115M
| $53.5M | 13.89% |
3,829,209
| – | – |
|
|
BPMC
3
DELISTED
Blueprint Medicines
BPMC
| $39.5M | 10.25% |
448,512
+25,500
| +6% | +$2.24M |
|
4
Arrowhead Research
ARWR
$3.51B
| $35.9M | 9.32% |
432,926
+25,000
| +6% | +$2.07M |
|
|
5
uniQure
QURE
$920M
| $35.7M | 9.26% |
1,157,513
+202,089
| +21% | +$6.22M |
|
6
Dianthus Therapeutics
DNTH
$770M
| $26.3M | 6.83% |
2,687,183
+184,973
| +7% | +$1.81M |
|
|
NGM
7
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $23.6M | 6.12% |
1,194,237
+70,000
| +6% | +$1.38M |
|
8
Regenxbio
RGNX
$464M
| $23.1M | 6.01% |
595,444
+36,000
| +6% | +$1.4M |
|
|
9
4D Molecular Therapeutics
FDMT
$285M
| $22.8M | 5.92% |
945,382
+644,496
| +214% | +$15.5M |
|
|
AMYT
10
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $13.8M | 3.59% |
1,140,000
+340,000
| +43% | +$4.12M |
|
|
PVLA
11
Palvella Therapeutics, Inc. Common Stock
PVLA
$577M
| $12.2M | 3.18% |
3,196,527
-479,003
| -13% | -$1.83M |
|
|
HARP
12
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $9.89M | 2.57% |
712,674
-841,525
| -54% | -$11.7M |
|
13
Galapagos
GLPG
$2.05B
| $9.81M | 2.55% |
142,340
+25,617
| +22% | +$1.76M |
|
14
argenx
ARGX
$42.8B
| $6.38M | 1.66% |
21,200
| – | – |
|
15
Genmab
GMAB
$15.9B
| $4.9M | 1.27% |
120,000
| – | – |
|
16
SPDR S&P 500 ETF Trust
SPY
$650B
| – | – |
0
| – | – |
|
17
SPDR S&P Biotech ETF
XBI
$5.23B
| – | – |
0
| – | – |
|